Immunotherapy for HIV-associated non-Hodgkin's lymphoma

By Newsom-Davis Thomas   Ahamed Eliyaz   Bower Mark  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 10, 2009-10 ,pp. : 1313-1324

Informa Healthcare

Access to resources Recommend Favorite

Rituximab in the treatment of non-Hodgkin's lymphoma – a critical evaluation of randomized controlled trials

By Griffin Morag Meriel   Morley Nick  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 803-811

Informa Healthcare

Access to resources Recommend Favorite

BiovaxID™: a personalized therapeutic cancer vaccine for non-Hodgkin’s lymphoma

By Lee Seung-Tae   Jiang Yun-Fang   Park Keon-Uk   Woo Alison F   Neelapu Sattva S  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 113-122

Informa Healthcare

Access to resources Recommend Favorite

⁹⁰Yttrium–ibritumomab tiuxetan: a novel treatment for non-Hodgkin’s lymphoma

By Blum Kristie A   Bartlett Nancy L  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1323-1331

Informa Healthcare

Access to resources Recommend Favorite

Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphoma

By Moscato Tiziana   Fedele Roberta   Messina Giuseppe   Irrera Giuseppe   Console Giuseppe   Martino Massimo  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 7, 2013-09 ,pp. : 1013-1027

Informa Healthcare

Access to resources Recommend Favorite